This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
5 ETF Buying Zones on Market Gyrations
by Sweta Killa
Given the latest economic developments, investors should stash their cash in some safe investing zones.
Is WisdomTree International Hedged Quality Dividend Growth ETF (IHDG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for IHDG
Dividend Growth ETFs to Fight Second Wave of Coronavirus Fears
by Sweta Jaiswal, FRM
The appeal of dividend ETFs has been rising in the face of easing monetary policy on the global front, and market uncertainty triggered by the pandemic and deceleration in global growth.
The Zacks Analyst Blog Highlights: VIG, SDY, DVY, SCHD and DGRO
by Zacks Equity Research
The Zacks Analyst Blog Highlights: VIG, SDY, DVY, SCHD and DGRO
A Quick Guide to Dividend Aristocrat ETFs
by Sweta Killa
Dividend aristocrats are the blue-chip dividend-paying companies with a long history of raising dividend payments year over year.
Here's Why Dividend Growth ETFs Make a Smarter Pick Now
by Sweta Jaiswal, FRM
The appeal of dividend ETFs has been rising in the face of easing monetary policy on the global front, market uncertainty triggered by the pandemic and deceleration in global growth.
Is WisdomTree International Hedged Quality Dividend Growth ETF (IHDG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for IHDG
Is Fear for Dividend Cuts Overblown? ETFs to Benefit
by Sanghamitra Saha
The fear for dividend ETF investing is possibly exaggerated as dividend cuts have been way fewer than hikes in the year-to-date frame.
Play These Dividend Growth ETFs Amid Coronavirus Crisis
by Sweta Jaiswal, FRM
Here we highlight some dividend growth ETFs for investors to consider as the coronavirus outbreak continues to wreak havoc.
6 Healthy ETFs Amid Coronavirus-Hit Economy
by Sweta Killa
On World Health Day, we would like to draw investors' attention to some ETFs that can make their portfolio immune to the effects of the coronavirus crisis, which has resulted in lockdowns and forced people to stay indoors.